Evidence map›Paper›PMID 32506995›Full record

ArticleRNA biology2020

Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer.

Zhao Zhang, Wei Yu, Dan Tang, Yufan Zhou, Mingjun Bi, Hu Wang, Yan Zheng, Mingqiu Chen, Li Li, Xinping Xu and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in RNA biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Roles of enhancer RNAs in sex hormone-dependent cancers.Journal of cancer research and clinical oncology · 2022
    Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Zhao ZhangDepartment of Molecular Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio , San Antonio, TX, USA.
Wei YuDepartment of Molecular Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio , San Antonio, TX, USA.
Dan TangDepartment of Molecular Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio , San Antonio, TX, USA.
Yufan ZhouDepartment of Molecular Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio , San Antonio, TX, USA.ORCID 0000-0002-8385-433X
Mingjun BiDepartment of Molecular Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio , San Antonio, TX, USA.ORCID 0000-0001-8748-2636
Hu WangDepartment of Molecular Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio , San Antonio, TX, USA.
Yan ZhengDepartment of Molecular Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio , San Antonio, TX, USA.
Mingqiu ChenDepartment of Radiation Oncology, Fujian Cancer Hospital & Fujian Medical University , Fuzhou, China.ORCID 0000-0001-7928-172X
Li LiDepartment of Oncology, The Second People's Hospital of Jiaozuo , Jiaozuo City, Henan, China.
Xinping XuJiangxi Institute of Respiratory Disease, the Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University , Nanchang, Jiangxi, China.ORCID 0000-0002-9568-4171
Wei ZhangJiangxi Institute of Respiratory Disease, the Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University , Nanchang, Jiangxi, China.
Huimin TaoDepartment of Orthopedics, The Second Affiliated Hospital, School of Medicine, Zhejiang University , Hangzhou, Zhejiang, China.
Victor X JinDepartment of Molecular Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio , San Antonio, TX, USA.ORCID 0000-0002-8765-3471
Zhijie LiuDepartment of Molecular Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio , San Antonio, TX, USA.ORCID 0000-0001-6956-7839
Lizhen ChenDepartment of Molecular Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio , San Antonio, TX, USA.ORCID 0000-0001-5313-7340
The University of Texas Health Science Center at San Antonio · USNanchang University · CNFujian Medical University · CNJiaozuo University · CNSecond Affiliated Hospital of Zhejiang University · CN

Funding

TRANSGENIC COREP30AG013319 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI PETER J HORNSBY · 1995 to 2026
$30.6M
Systems Analysis of Epigenomic Architecture in Cancer ProgressionU54CA217297 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JIN, VICTOR · 2017 to 2021
$9.3M
Novel Coregulators of Estrogen Receptor in Enhancer-regulated TranscriptionR01GM137009 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LIU, ZHIJIE "JASON" · 2020 to 2023
$1.0M
NCI NIH HHS U54 CA217297NIA NIH HHS P30 AG013319NIGMS NIH HHS R01 GM137009
6 · The paper itself

Abstract

Breast cancer is one of the most prevalent cancers in women worldwide. Through the regulation of many coding and non-coding target genes, oestrogen (E

Indexed as

Epigenesis, GeneticGene Expression Regulation, NeoplasticApoptosisBiomarkers, TumorBreast NeoplasmsCell Line, TumorComputational BiologyEnhancer Elements, GeneticEstrogen Receptor alphaEstrogensFemaleGene Expression ProfilingHumansImmunophenotypingReceptors, EstrogenResponse ElementsBiomarkers, TumorESR1 protein, humanEstrogen Receptor alphaEstrogensReceptors, EstrogenRNA, Long Noncodingbreast cancerEpigenomics-basedidentificationlong noncoding RNAoestrogen

Identifiers

PMID32506995
PMCPMC7567493
OpenAlexW3034112704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.